Please assess the completion status of the following clinical trial:

Trial Title: Duration of Antibiotics Treatment With Cefazolin and Clarithromycin in Women With Preterm Premature Rupture of Membrane

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* preterm premature rupture of membrane(PPROM), PA 22+0\~34+0wks~* ROM \<72 hrs before randomization~* cervical dilatation \<3cm~* uterine contraction less than 4 times per 1 hr~Exclusion Criteria:~* Major fetal malformation~* Rupture of the membrane \>72hrs before randomization~* Vaginal bleeding~* IIOC (incompetent internal os of cervix)~* Placenta previa~* Gestational diabetes or overt diabetes~* Hypertensive disorders in pregnancy~* Liver cirrhosis~* Acute renal failure

- Gender: FEMALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- one-week treatment group (Type: ACTIVE_COMPARATOR): Cefazolin 1.0gm IVs q 12 hours plus clarithromycin 500mg po bid after randomization for one week
- until-delivery treatment group (Type: ACTIVE_COMPARATOR): Cefazolin 1.0gm IVs q 12 hours plus clarithromycin 500mg po bid after randomization until delivery

Based on this trial design, predict the completion outcome and termination type (if applicable).